Javascript must be enabled to continue!
Hepatocellular Carcinoma: Risk Factors and Diagnosis
View through CrossRef
Hepatocellular carcinoma, also known as hepatocarcinoma, is the most frequent type of primary liver cancer and the world's second leading cause of death, with a mortality rate of 700.000 per year. Due to the difficulty in diagnosing hepatocarcinoma because there are no obvious symptoms, the survival rate of hepatocarcinoma patients is still very low, particularly in Southeast Asian countries. Hepatocarcinoma is still a major health issue in Indonesia, with a very low median survival rate. The number of risk factors that cause hepatocarcinoma is what causes differences in hepatocarcinoma incidence across countries. This literature review aims to determine risk factors and to confirm the diagnosis of hepatocarcinoma. This literature review was conducted using the keywords “Hepatocellular Carcinoma AND risk factors AND diagnosis” from PubMed, Google Scholar, and non-peer-reviewed literature. This article uses 16 articles that were used as references in its preparation. In conclusion, hepatitis B and C virus, liver cirrhosis, fatty liver disease, diabetes, alcohol use, aflatoxin exposure, aristolochic acid exposure, smoking, and HIV are risk factors for hepatocarcinoma. On all individuals with hepatocarcinoma risk factors, screening procedures with US and AFP were carried out. An abdominal CT scan or an MRI with contrast can both be used to provide a firm diagnosis of hepatocarcinoma. A liver biopsy is used to confirm the diagnosis of space-occupying lesions that lack typical imaging characteristics.
Title: Hepatocellular Carcinoma: Risk Factors and Diagnosis
Description:
Hepatocellular carcinoma, also known as hepatocarcinoma, is the most frequent type of primary liver cancer and the world's second leading cause of death, with a mortality rate of 700.
000 per year.
Due to the difficulty in diagnosing hepatocarcinoma because there are no obvious symptoms, the survival rate of hepatocarcinoma patients is still very low, particularly in Southeast Asian countries.
Hepatocarcinoma is still a major health issue in Indonesia, with a very low median survival rate.
The number of risk factors that cause hepatocarcinoma is what causes differences in hepatocarcinoma incidence across countries.
This literature review aims to determine risk factors and to confirm the diagnosis of hepatocarcinoma.
This literature review was conducted using the keywords “Hepatocellular Carcinoma AND risk factors AND diagnosis” from PubMed, Google Scholar, and non-peer-reviewed literature.
This article uses 16 articles that were used as references in its preparation.
In conclusion, hepatitis B and C virus, liver cirrhosis, fatty liver disease, diabetes, alcohol use, aflatoxin exposure, aristolochic acid exposure, smoking, and HIV are risk factors for hepatocarcinoma.
On all individuals with hepatocarcinoma risk factors, screening procedures with US and AFP were carried out.
An abdominal CT scan or an MRI with contrast can both be used to provide a firm diagnosis of hepatocarcinoma.
A liver biopsy is used to confirm the diagnosis of space-occupying lesions that lack typical imaging characteristics.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Evaluating the GALAD Score in Diagnosing Hepatocellular Carcinoma
Evaluating the GALAD Score in Diagnosing Hepatocellular Carcinoma
This paper aims to evaluate the GALAD score in diagnosing hepatocellular carcinoma. The paper conducted a retrospective study of 86 Hepatocellular Carcinoma patients who underwent ...
Risk prediction for Dermatomyositis-associated hepatocellular carcinoma
Risk prediction for Dermatomyositis-associated hepatocellular carcinoma
Abstract
Objective
To explore dermatomyositis signature genes as potential biomarkers of hepatocellular carcinoma and their associated molecular regulatory mechanisms.
Meth...
Long-term outcomes of laparoscopic hepatectomy for hepatocellular carcinoma at Viet Duc University Hospital from 2019 to 2023
Long-term outcomes of laparoscopic hepatectomy for hepatocellular carcinoma at Viet Duc University Hospital from 2019 to 2023
Abstract
Introduction: Laparoscopic liver resection is a challenging procedure, yet it is increasingly applied in the treatment of hepatocellular carcinoma (HCC), including our c...
Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI
Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI
Objective
To evaluate the diagnostic performance of iodine-enhanced multidetector CT and gadoxetic acid-enhanced 3.0 Tesla (T) MRI for detection of hepatocellul...
PERBANDINGAN INDEKS ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX (APRI) PADA PASIEN SIROSIS HEPATIS DAN KARSINOMA HEPATOSELULER
PERBANDINGAN INDEKS ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX (APRI) PADA PASIEN SIROSIS HEPATIS DAN KARSINOMA HEPATOSELULER
ABSTRAK
Sirosis hepatis dianggap sebagai kondisi sebelum terjadinya karsinoma hepatoseluler. Sirosis hepatis dan karsinoma hepatoseluler perlu dideteksi lebih awal dengan men...
Gene Expression Characteristics of Liver Tissue Reveal the Underlying Pathogenesis of Hepatocellular Carcinoma
Gene Expression Characteristics of Liver Tissue Reveal the Underlying Pathogenesis of Hepatocellular Carcinoma
Background. Hepatocellular carcinoma (HCC) is high‐mortality primary liver cancer and the most common malignant tumor in the world. This study is based on a hepatocellular carcinom...

